Our Genomics Medicine programme follows a curriculum designed by Health Education England and is aligned with the 100,000 genomes project, led by Genomics England and NHS England, which intends to transform the use of genomic medicine in the NHS. This course is jointly taught by both King’s and St George’s, University of London, allowing you to benefit from the breadth of expertise provided by both institutions including their membership of the South London NHS Genome Medicine Centre. The programme is suitable for healthcare professionals and other students with an interest in Genomic Medicine.
Our Genomic Medicine programme, taught jointly with St George’s, is an opportunity to explore how recent technological advances have transformed the way that genetic data is generated, analysed and presented, and its relevance to a range of clinical scenarios.
The Genomics Medicine programme is designed for healthcare professionals and other students who wish to train in genomic technologies and the interpretation of genomic data within a medical context.
The study programme is made up of optional and required modules. The MSc pathway requires modules totalling 180 credits to complete the programme, including either 60 or 30 credits from a research project and dissertation or literature review. The Postgraduate Diploma pathway requires modules totalling 120 credits, while the Postgraduate Certificate requires you to study modules totalling 60 credits to complete the course. If you are studying full-time, you will complete the course in one year, from September to September. If you are studying part-time, your programme will take two years to complete.
The Genomics Medicine programme is designed for healthcare professionals and other students who wish to acquire training in genomic technologies and the interpretation of their findings within a medical context.
Modules taught in one week blocks including face to face and on line teaching. Learning material delivered as lectures, tutorials and workshops. Each taught module assessed by two pieces of assessment that varies between modules and include multiple choice questions, extended essays, case studies or role play.
An MSc in Genomic Medicine will provide career opportunities for a range of professions from laboratory based researchers to diagnostic and healthcare professionals.
Our degrees in Genomic Medicine cover all aspects of genomic science and medicine, and will equip you with the knowledge and skills to be able to interpret and understand genomic data that increasingly impacts on service delivery to patients and the community.
The programme is aimed at students from a wide range of backgrounds, from basic scientists to all levels of healthcare professionals, and will provide a flexible, multi-disciplinary and multi-professional perspective in genomics, applied to clinical practice and medical research.
It is designed to equip you with the knowledge and skills to be able to interpret and understand genomic data that increasingly impacts on service delivery to patients and the community.
The training provided covers all aspects of genomic science and medicine (not merely DNA sequencing or detection of genetic variation), undertaken in one of the most cutting-edge scientific environments.
The course includes collaborations with:
The Institute of Cancer Research and Brunel University London may also co-supervise research projects.
This course is made up of three progressional levels (PG Cert, PG Dip and MSc), and you can apply to any level in the first instance. Read more about how this works under 'Choosing your course' in the admissions section.
One of the core modules available within the Master's degree (MSc) includes opportunities to access the emerging data from the 100,000 Genomes Project through the Genomics England Clinical Interpretation Partnership (GeCIP) training domains.
Hear from Genomic Medicine students and graduates on the National Heart and Lung Institute website.
A blended approach to learning is used, in both core and optional modules, combining face-to-face teaching and online distance learning. This is to provide flexibility for health professionals to combine their study with work.
Most modules will consist of one week of face-to-face teaching and up to three weeks of e-learning and independent study. The modules are offered on a cycle of 12 months, so that all modules become available once in each 12 month cycle.
The course is flexible and modular and is available as a full-time or part-time MSc delivered over one or two years respectively. There are also full-time and part-time Postgraduate Certificate (PG Cert) and Postgraduate Diploma (PG Dip) options.
The central goal of the Division of Pathway Medicine (DPM) is to integrate post-genomic science with medicine in order to provide a better understanding of disease processes. This will provide the basis for the development of new medical innovations for the diagnosis and treatment of human diseases. To do this the DPM promotes multidisciplinary interactions between science and medicine.
The DPM has two main research themes:
The DPM offers leading-edge multidisciplinary PhD training and research in the application of postgenomic technologies and analytical methodologies for the study of disease pathways and processes.
The DPM has regular seminar speakers and hosts a yearly international conference on pathway medicine. Students attend DPM seminars and the generic skills-training programme provided by the life-sciences graduate programme. Students are invited to the annual DPM scientific workshop held at the Firbush Centre in Perthshire.
The DPM fosters an integrative and multidisciplinary approach to disease pathway analysis. Students have access to state-of-the-art facilities for high throughput genomic and proteomic studies and biochip applications, including dedicated laboratories for the study of virus-host interactions.
The Division also houses leading bioinformatics and IT infrastructure and expertise for the integrative analysis and modelling of high throughput genomic and proteomic data. Complementing this, the DPM is also leading the development of computational approaches for the construction and modelling of disease pathways.